Imatinib administration in two patients with liver metastases from GIST and severe jaundice

af De Pas, T, Danesi, R, Catania, C, Curigliano, G, de Braud, F
Udgivet 2003

Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.

af Delia, D, Cattoretti, G, Bonati, A, Villa, S, De Braud, F, Buscaglia, M
Udgivet 1985

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy

af Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M.
Udgivet i ESMO Open (2021)

Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group

af De Pas, T, Bodei, L, Pelosi, G, de Braud, F, Villa, G, Capanna, R, Paganelli, G
Udgivet 2003

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature

af Spada, F, Pelosi, G, Squadroni, M, Lorizzo, K, Farris, A, de Braud, F, Fazio, N
Udgivet 2011

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies

af Procopio, G, Verzoni, E, Iacovelli, R, Biasoni, D, Testa, I, Porcu, L, De Braud, F
Udgivet 2012

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

af Verzoni E, Grassi P, Testa I, Iacovelli R, Biondani P, Garanzini E, De Braud F, Procopio G
Udgivet 2014-03-01

Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

af De Pas, T, Spitaleri, G, Vigna, PD, Toffalorio, F, Curigliano, G, Gambino, A, Boselli, S, Catania, C, de Braud, F
Udgivet 2008

QTc prolongation assessment in anticancer drug development: clinical and methodological issues

af Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Udgivet 2009

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

af Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Udgivet 2003

1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study

af Nichetti, F., Bini, M., Dotti, K.F., Ottini, A., Ambrosini, M., Rametta, A., Leporati, R., Ferrari, L., De Braud, F.G.M.
Udgivet i Ann Oncol (2020)

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

af Janot, F., Klijanienko, J., Russo, A., Mamet, J. P., de Braud, F., El-Naggar, A. K., Pignon, J. P., Luboinski, B., Cvitkovic, E.
Udgivet 1996

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

af Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Rossoni, G, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C
Udgivet 2010

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

af Joensuu, H, De Braud, F, Grignagni, G, De Pas, T, Spitalieri, G, Coco, P, Spreafico, C, Boselli, S, Toffalorio, F, Bono, P, Jalava, T, Kappeler, C, Aglietta, M, Laurent, D, Casali, P G
Udgivet 2011

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

af Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F.
Udgivet i NPJ Precis Oncol (2021)

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy

af Ortolan, E., Appierto, V., Silvestri, M., Miceli, R., Veneroni, S., Folli, S., Pruneri, G., Vingiani, A., Belfiore, A., Cappelletti, V., Vismara, M., Dell'Angelo, F., De Cecco, L., Bianchi, G.V., de Braud, F.G., Daidone, M.G., Di Cosimo, S.
Udgivet i ESMO Open (2021)

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology

af Biffi, R, Orsi, F, Zampino, MG, Chiappa, A, Fazio, N, De Braud, F, Bonomo, G, Monfardini, L, Vigna, PD, Luca, F, Bodei, L, Bartolomei, M, Catalano, G, Leonardi, MC, Ferrari, M, Andreoni, B, Goldhirsch, A, Paganelli, G, Orecchia, R
Udgivet 2008

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

af Jonker, D. J., Rosen, L. S., Sawyer, M. B., de Braud, F., Wilding, G., Sweeney, C. J., Jayson, G. C., McArthur, G. A., Rustin, G., Goss, G., Kantor, J., Velasquez, L., Syed, S., Mokliatchouk, O., Feltquate, D. M., Kollia, G., Nuyten, D. S. A., Galbraith, S.
Udgivet 2011

Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognost...

af Necchi, A, Pennati, M, Zaffaroni, N, Landoni, E, Giannatempo, P, Raggi, D, Schwartz, L H, Morosi, C, Crippa, F, Farè, E, Nicolai, N, Lanocita, R, Sava, T, Sacco, C, Messina, C, Ortega, C, De Braud, F G, Salvioni, R, Daidone, M G, Gianni, A M, Mariani, L
Udgivet 2014

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

af Long, G. V., Flaherty, K. T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J. B. A. G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M. A., Lane, S. R., Legos, J. J., Mookerjee, B., Grob, J.-J.
Udgivet i Ann Oncol (2017)